Solitaire X
Payments companies reported to CMS as associated with Solitaire X. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Solitaire X, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Solitaire X
These are the largest totals companies reported as associated with Solitaire X. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeffrey Beecher | Wilmington, NC | Neurological Surgery | $2,887.79 |
| Jenny Peih-Chir Tsai | Cleveland, OH | Vascular Neurology | $2,743.90 |
| Julius Griauzde | Novi, MI | Neuroradiology | $2,635.45 |
| Daniel Sahlein | Carmel, IN | Vascular & Interventional Radiology | $2,478.48 |
| Pouya Entezami | Clinton Township, MI | Neurological Surgery | $2,386.95 |
| Fazeel Siddiqui | Wyoming, MI | Vascular Neurology | $2,386.60 |
| Wolfgang Leesch | Newport News, VA | Vascular Neurology | $2,361.58 |
| David Rosenbaum | Traverse City, MI | Vascular Neurology | $2,210.04 |
| Christopher Storey | Hermitage, TN | Neurological Surgery | $2,187.97 |
| Katyucia De Macedo Rodrigues | Greensboro, NC | Neuroradiology | $1,998.49 |
Prescribed Solitaire X?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.